Logo

NYU Langone Health Perlmutter Cancer Center Clinical Whole-Genome DNA Methylation Profiling for Brain Tumors

Oct 25, 2019

NYU Langone Health's Perlmutter Cancer Center has launched clinical whole-genome DNA methylation profiling for patients with brain tumors. This molecular assay utilizes DNA epigenetic signatures and artificial intelligence with machine learning to identify and subtype brain tumors.

The test received New York State Department of Health approval on April 3.  

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.